Insider Transactions in Q3 2024 at Enhabit, Inc. (EHAB)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 22
2024
|
Jeffrey Bolton Director |
BUY
Open market or private purchase
|
Direct |
5,000
+5.96%
|
$40,000
$8.01 P/Share
|
|
Aug 09
2024
|
Jeffrey Bolton Director |
BUY
Open market or private purchase
|
Direct |
5,000
+6.34%
|
$40,000
$8.29 P/Share
|
|
Aug 08
2024
|
Jeffrey Bolton Director |
BUY
Open market or private purchase
|
Direct |
2,000
+2.82%
|
$16,000
$8.6 P/Share
|
|
Jul 25
2024
|
Barry P. Schochet Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,578
+28.54%
|
$145,780
$10.29 P/Share
|
|
Jul 25
2024
|
Charles M Elson Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,578
+22.8%
|
$145,780
$10.29 P/Share
|
|
Jul 25
2024
|
Tina L. Brown Stevenson Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,578
+28.31%
|
$145,780
$10.29 P/Share
|
|
Jul 25
2024
|
Jeffrey Bolton Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,578
+17.9%
|
$145,780
$10.29 P/Share
|
|
Jul 25
2024
|
Stuart M Mcguigan Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,578
+33.32%
|
$145,780
$10.29 P/Share
|
|
Jul 25
2024
|
Gregory S Rush Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,578
+24.94%
|
$145,780
$10.29 P/Share
|
|
Jul 25
2024
|
Erin Hoeflinger Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,578
+24.48%
|
$145,780
$10.29 P/Share
|
|
Jul 01
2024
|
Julie Diane Jolley EVP of Home Health Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,302
-1.82%
|
$10,416
$8.75 P/Share
|
|
Jul 01
2024
|
Crissy Buchanan Carlisle Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,779
-2.01%
|
$14,232
$8.75 P/Share
|
|
Jul 01
2024
|
Ronald Leroy Langham Jr EVP Clinical Excel. & Strategy |
SELL
Payment of exercise price or tax liability
|
Direct |
673
-1.18%
|
$5,384
$8.75 P/Share
|